As a supporting example, a panel consisting of CEA, CYFRA 21-1, neuron-specific enolase (NSE), SCC, and ProGRP demonstrated higher diagnostic sensitivity (88,5%) and specificity (82%) than each marker alone in detecting lung cancer in patients with symptoms suggestive of this cancer [70]. The gene discussed is ENO2; the disease is lung carcinoma.